BSEBoard Meeting2d ago · 23 Sept 2026, 05:07 pm
The Board of Director at its meeting held today i.e. Wednesday, September 23, 2026, has inter-alia considered and approved Issuance of Bonus shares & Increase in the Authorised Share Capital of the Company and consequent amendment to Clause V regarding Authorised Share Capital of Memorandum of Association of the Company.
Concord Biotech Ltd · 543960
✦ AI SummaryBonus/Split
Concord Biotech Ltd has approved the issuance of bonus shares in the ratio of 1:1 and an increase in the authorized share capital from Rs. 11,00,00,000 to Rs. 22,00,00,000, subject to shareholder approval.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Concord Biotech Ltd - 543960 - Board Meeting Outcome for The Board Of Director At Its Meeting Held Today I.E. Wednesday, September 23, 2026, Has Inter-Alia Considered And Approved Issuance Of Bonus Shares & Increase In The Authorised Share Capital Of The Company.